Multi-Institutional Validation of a Mammography-Based Breast Cancer Risk Model
Journal of Clinical Oncology2021Vol. 40(16), pp. 1732–1740
Citations Over TimeTop 1% of 2021 papers
Adam Yala, Peter G. Mikhael, Fredrik Strand, Gigin Lin, Siddharth Satuluru, Thomas Kim, Imon Banerjee, Judy Wawira Gichoya, Hari Trivedi, Constance D. Lehman, Kevin S. Hughes, David J. Sheedy, Lisa M. Matthis, Bipin Karunakaran, Karen E. Hegarty, Silvia Maria Prioli de Souza Sabino, Thiago Buosi Silva, Maria C. Evangelista, Renato F. Caron, Bruno Souza, Edmundo Carvalho Mauad, Tal Patalon, Sharon Handelman-Gotlib, Michal Guindy, Regina Barzilay
Abstract
Mirai, a mammography-based risk model, maintained its accuracy across globally diverse test sets from seven hospitals across five countries. This is the broadest validation to date of an AI-based breast cancer model and suggests that the technology can offer broad and equitable improvements in care.
Related Papers
- → Parental non-concordance with occlusion therapy(2000)101 cited
- → The Promise and Limits of Racial/Ethnic Concordance in Physician-Patient Interaction(2006)54 cited
- → How to Improve the Drafting of Health Profiles(2022)2 cited
- → Concordance with Medication and Older People(2007)
- A concordance to King Horn ; a concordance to Athelston ; a concordance to Gamelyn(1986)